The global demand for Bioresorbable Vascular Scaffold Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
The bioresorbable vascular scaffold, a non-metallic mesh tube, is used to treat a constricted & blocked artery. It is designed to aid in unclogging a blocked artery in the heart & revive blood flow to the heart muscle. Similar to a stent, it slowly dissolves as the blocked artery starts to function normally once again and remains open on its own. Once the artery is open, it dissolves on its own, potentially enabling the blood vessel to function naturally.
Market Dynamics
The rising demand for effective biocompatible coronary stents is the main factor propelling the market growth of bioresorbable coronary scaffolds. The increasing need for bioresorbable scaffold and the rise in the prevalence of cardiovascular and heart diseases is further fostering the growth of the bioresorbable vascular scaffold market. In addition, changing lifestyles and junk food intake have led to obesity and several chronic ailments. Therefore, bioresorbable scaffolds are essential in cardiovascular procedures. As a result, increasing chronic ailments coupled with the advantages of the bioresorbable vascular scaffold will flourish its market growth in upcoming years. The surge in R&D activities and increasing efforts by healthcare organizations and governments regarding cardiovascular diseases will further augment market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of bioresorbable vascular scaffold. The growth and trends of bioresorbable vascular scaffold industry provide a holistic approach to this study.
Market Segmentation
This section of the bioresorbable vascular scaffold market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product Type
By Material Type
- Metal Based BVS
- Polymer Based BVS
By Application
- Coronary Artery Stents
- Peripheral Artery Stents
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Centers
- Others
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Bioresorbable Vascular Scaffold market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Bioresorbable Vascular Scaffold Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the bioresorbable vascular scaffold market include Abbott Laboratories, Cook Medical, Boston Scientific Corporation, B. Braun Melsungen AG, Medtronic Plc, Stentys SA, MAQUET Holding B.V. & Co. KG (Getinge AB), W.L. Gore & Associates, C. R. Bard, Inc., Theragenics Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.